Induction of bone marrow stromal cells into GABAergic neuronal phenotype using creatine as inducer.
OBJECTIVE
Deficits involving GABAergic neurons have been reported in aging, central nervous trauma and neurodegenerative disorders; bone marrow stromal cells (BMSCs) have been proposed as a feasible source of donor cells in replacement cell therapy. In this study, the effects of creatine on transdifferentiating BMSCs into GABAergic-like neurons were evaluated in vitro.


METHODS
The BMSCs were isolated from adult rats, preinduced by β-mercaptoethanol (BME) and retinoic acid (RA), and then induced by creatine into GABAergic-like neurons. The cells were characterized using different differentiation markers. The functionality of the differentiated cells was evaluated using FM1-43.


RESULTS
The isolated cells expressed Oct-4 and were immunoreactive to fibronectin and CD44. The highest percentages of cells immunoreactive to nestin and neurofilament-68 were found at the second day of preinduction. At the induction stage, there were increases in the number of cells immunoreactive to neurofilament-200, MAP-2, synapsin I, synaptophysin, and NeuN. The percentages of the immunoreactive cells to GABAergic neuron markers increased. The optimal induction dose was 5 mM. The dose of 10 mM showed a decline in the expression of most of these markers. The functionality test indicated that the synaptic vesicles were released upon stimulation.


CONCLUSIONS
Creatine can induce the differentiation of BMSCs to the GABAergic neuronal phenotype within one week.
Department of Anatomical Sciences, Tarbiat Modares and Shefa Neuroscience Research Center, Khatam Al-Anbia Hospital, University, Tehran, Iran.
Payam
P
Mohammad-Gharibani
Taki
T
Tiraihi
Seyed Alireza
SA
Mesbah-Namin
Jalil
J
Arabkheradmand
Hadi
H
Kazemi
D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects* / Q000502:physiology; D002478:Cells, Cultured; D003401:Creatine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D059330:GABAergic Neurons / Q000166:cytology* / Q000378:metabolism; D016130:Immunophenotyping; D066298:In Vitro Techniques; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000378:metabolism; D058953:Neural Stem Cells / Q000166:cytology* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013572:Synaptic Vesicles / Q000378:metabolism
D015415:Biomarkers; D003401:Creatine